Dow Jones

42 544,22

-0,07%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Canadá
TSXV
Arch Biopartners Inc (ARCH)
Arch Biopartners Inc (ARCH) Actualités

ARCH

Arch Biopartners (ARCH)

Arch Biopartners Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:TSXV:ARCH

Date	Heure	Source	Titre	Symbole	Société
11/11/2024	19h46	AllPennyStocks.com	Dosing of First Patient in a Trial for LSALT Peptide is Sending Shares HIgher	TSXV:ARCH	Arch Biopartners Inc
15/12/2020	19h08	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ARCH	TSXV:ARCH	Arch Biopartners Inc
15/12/2020	19h05	PR Newswire (Canada)	IIROC Trading Resumption - ARCH	TSXV:ARCH	Arch Biopartners Inc
15/12/2020	17h37	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ARCH	TSXV:ARCH	Arch Biopartners Inc
15/12/2020	17h35	PR Newswire (Canada)	IIROC Trading Halt - ARCH	TSXV:ARCH	Arch Biopartners Inc
05/11/2020	14h34	InvestorsHub NewsWire	Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial to Treat Complications from Covid-19	TSXV:ARCH	Arch Biopartners Inc
16/10/2020	16h30	InvestorsHub NewsWire	First Patient Dosed in Phase II Trial to Treat Complications in COVID-19	TSXV:ARCH	Arch Biopartners Inc
08/06/2020	14h30	InvestorsHub NewsWire	Arch Biopartners submits IND to the FDA for COVID-19 Phase II trial to prevent organ inflammation.	TSXV:ARCH	Arch Biopartners Inc
08/05/2020	14h03	InvestorsHub NewsWire	Arch Biopartners Receives Health Canada Approval for COVID-19 Phase II Human Trial	TSXV:ARCH	Arch Biopartners Inc
24/04/2020	13h18	InvestorsHub NewsWire	Arch Biopartners Applies to Health Canada to Conduct COVID19 Phase II Human Trial to Prevent Lung and Kidney Inflammation	TSXV:ARCH	Arch Biopartners Inc
26/09/2018	15h29	PR Newswire (Canada)	Arch Biopartners Announces Completion of GMP Manufacturing of Metablok Vials	TSXV:ARCH	Arch Biopartners Inc
14/08/2018	15h23	PR Newswire (Canada)	Arch Biopartners Engages Dalton Pharma Services for GMP Manufacturing of Metablok	TSXV:ARCH	Arch Biopartners Inc